|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||303.72 - 309.89|
|52 Week Range||186.09 - 313.25|
|PE Ratio (TTM)||52.08|
|Earnings Date||Jul 23, 2018 - Jul 27, 2018|
|Forward Dividend & Yield||1.12 (0.40%)|
|1y Target Est||266.50|
Solid performance in Renal Products, Medication Delivery, Pharmaceutical and Other segment boost Baxter's (BAX) Q1 results.
Miami, FL, April 24, 2018-- VITAS ® Healthcare will share its expertise as the nation’ s leading provider of end-of-life care at the 2018 Blue Cross Blue Shield National Summit being held May 1-4, 2018 ...
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Chemed Corporation (NYSE: CHE ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 20, 2018 at 10:00 AM Eastern Time. To ...
The Cincinnati-based company said it had net income of $2.66 per share. Earnings, adjusted for non-recurring costs, came to $2.72 per share. The operator of the Roto-Rooter plumbing service and Vitas Healthcare ...
Chemed Corporation , which operates VITAS Healthcare Corporation , the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s large
Miami, FL, April 18, 2018-- VITAS ® Healthcare, the nation’ s leading provider of end-of-life care, will be a contributing sponsor for the America’ s Physician Groups national conference,“ Taking Responsibility ...
On a positive note, the broader healthcare looks delighted with the massive tax cuts. Also, the scenario within the Medical Device space seems equally bright.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding CHE totaled $578 million.
Miami, FL, April 13, 2018-- VITAS ® Healthcare, the nation’ s leading provider of end-of-life care, will serve as an executive sponsor of“ The Business of Health Care: What’ s Next? ”a University of Miami ...
Chemed Corporation today announced that it will release financial results for the first quarter ended March 31, 2018, on Thursday, April 19, 2018, following the close of trading on the New York Stock Exchange.
Miami, FL, April 09, 2018-- The nation’ s leading hospice provider has developed the first mobile scanning referral app for practitioners. As easy as aim-snap-send, referrals to VITAS Healthcare are quick, ...
NEW YORK, March 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Chemed Corporation today announced that it will deliver a presentation at the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018, at approximately 10:20 a.m.
Chemed Corporation announced today that the Board of Directors has formally authorized an additional $150 million for stock repurchase under Chemed’s existing share repurchase program.
Chemed Corp (NYSE:CHE) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Chemed Corporation announced today that the Board of Directors has declared a quarterly cash dividend of 28-cents per share on the Company’s capital stock, payable on March 19, 2018, to shareholders of record as of February 26, 2018.
Chemed Corporation today announced that it will deliver a presentation at the RBC Capital Markets’ Global Healthcare Conference on Wednesday, February 21, 2018, at approximately 9:00 a.m.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
NEW YORK, NY / ACCESSWIRE / February 15, 2018 / Chemed Corporation (NYSE: CHE ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 15, 2018 at 10:00 AM Eastern Time. ...